We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Report Predicts More Use of Drug Special Designations in 2013
Report Predicts More Use of Drug Special Designations in 2013
February 11, 2013
U.S. and EU regulators hope to increase the use of special designations, such as fast track, priority review and accelerated approval, to speed access to drugs for noncancer diseases that are rare and/or life-threatening, according to a new Tufts University report.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor